C

CNS Pharmaceuticals
D

CNSP

5.95000
USD
-0.20
(-3.25%)
مغلق
حجم التداول
0
الربح لكل سهم
-10
العائد الربحي
-
P/E
-0
حجم السوق
8,695,622
أصول ذات صلة المقالات
المزيد

العنوان: CNS Pharmaceuticals Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.